HDAC1 and lung carcinoma: In contrast, the silencing of HDAC1 resulted in reduced expression of the transcription factors, Nanog and Oct4, in lung cancer stem cells and increased sensitivity to cisplatin treatment (Wang et al., 2017) (Figure 2).